Who Owns Sutro Biopharma Stock?
NASDAQ: STROHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 98.91%
- Institutions (% of float)
- 101.20%
- Held by insiders
- 2.26%
- Institutional holders
- 146
- Institutions 97.7%
- Insiders 2.3%
- Public and other 0.0%
Who owns Sutro Biopharma stock?
Institutional investors own about 98.9% of Sutro Biopharma's shares, spread across 146 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.26% of STRO.
The largest institutional holders are Perceptive Advisors Llc (7.87%), BVF Inc. (7.55%) and Affinity Asset Advisors, Llc (7.07%). Together, the top 10 institutions control 57.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their STRO positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of STRO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Perceptive Advisors Llc | 1.30M | 7.87% | +82.4% |
| BVF Inc. | 1.25M | 7.55% | 0.0% |
| Affinity Asset Advisors, Llc | 1.17M | 7.07% | +9.6% |
| Blackrock Inc. | 1.12M | 6.77% | +382.5% |
| Samsara BioCapital, LLC | 1.06M | 6.41% | 0.0% |
| Kynam Capital Management, LP | 872.56K | 5.26% | 0.0% |
| Orbimed Advisors LLC. | 743.94K | 4.49% | -7.1% |
| Balyasny Asset Management LP | 711.16K | 4.29% | +52.7% |
| Vanguard Capital Management LLC | 694.22K | 4.19% | -3.6% |
| Eventide Asset Management LLC | 585.26K | 3.53% | -18.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of STRO
| Fund | Shares | % Held |
|---|---|---|
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 585.26K | 3.53% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 501.52K | 3.02% |
| iShares Trust-iShares Russell 2000 ETF | 400.76K | 2.42% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 177.21K | 1.07% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 173.72K | 1.05% |
| Fidelity Covington Trust-Fidelity Enhanced Small Cap Core ETF | 156.58K | 0.94% |
| iShares Trust-iShares Russell 2000 Value ETF | 128.11K | 0.77% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 126.29K | 0.76% |
| Goldman Sachs Trust-Goldman Sachs Small Cap Equity Insights Fund | 77.19K | 0.47% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 75.12K | 0.45% |
Frequently asked questions
Who is the largest shareholder of Sutro Biopharma?
Perceptive Advisors Llc is the largest institutional shareholder of STRO, owning 7.87% of shares outstanding (1.30M shares) as of its latest 13F filing.
What percentage of Sutro Biopharma is owned by institutions?
Institutions own about 98.9% of STRO shares and 101.2% of the public float.
How much of Sutro Biopharma do insiders own?
Insiders, such as officers and directors, own about 2.26% of STRO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.